You are here


Scearce-Levie K, Roberson ED, Gerstein H, et al. "Abnormal social behaviors in mice lacking Fgf17." Genes Brain Behav.. 2008;7(3):344-54.
Finkbeiner S, Mitra S. "The ubiquitin-proteasome pathway in Huntington's disease." ScientificWorldJournal. 2008;8:421-33.
deIpolyi AR, Rankin KP, Mucke L, Miller BL, Gorno-Tempini ML. "Spatial cognition and the human navigation network in AD and MCI." Neurology. 2007;69(10):986-97.
Peebles CL, Finkbeiner S. "RNA decay back in play." Nat. Neurosci.. 2007;10(9):1083-4.
Singla S, Kreitzer AC, Malenka RC. "Mechanisms for synapse specificity during striatal long-term depression." J. Neurosci.. 2007;27(19):5260-4.
Roberson ED, Scearce-Levie K, Palop JJ, et al. "Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model." Science. 2007;316(5825):750-4.
Passino MA, Adams RA, Sikorski SL, Akassoglou K. "Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR." Science. 2007;315(5820):1853-6.
Barter P, Y McPherson R, Song K, et al. "Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia." J. Clin. Endocrinol. Metab.. 2007;92(6):2041-5.
Rao VR, Finkbeiner S. "NMDA and AMPA receptors: old channels, new tricks." Trends Neurosci.. 2007;30(6):284-91.
Nakamura K, Edwards RH. "Physiology versus pathology in Parkinson's disease." Proc. Natl. Acad. Sci. U.S.A.. 2007;104(29):11867-8.
Schachtrup C, Lu P, Jones LL, et al. "Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptor." Proc. Natl. Acad. Sci. U.S.A.. 2007;104(28):11814-9.
Paz JT, Chavez M, Saillet S, Deniau J-M, Charpier S. "Activity of ventral medial thalamic neurons during absence seizures and modulation of cortical paroxysms by the nigrothalamic pathway." J. Neurosci.. 2007;27(4):929-41.
Nakamura K, Aminoff MJ. "Huntington's disease: clinical characteristics, pathogenesis and therapies." Drugs Today. 2007;43(2):97-116.
Roses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley RW. "Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)." Pharmacogenomics J.. 2007;7(1):10-28.
Mahley RW, Huang Y, Weisgraber KH. "Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease." Curr Alzheimer Res. 2007;4(5):537-40.
Cheng IH, Scearce-Levie K, Legleiter J, et al. "Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models." J. Biol. Chem.. 2007;282(33):23818-28.